MYNZ (Mainz Biomed NV) EPS (Basic) : $-25.16 (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV EPS (Basic)?

Mainz Biomed NV's basic earnings per share (Basic EPS) for the three months ended in Dec. 2024 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was $-25.16.

Mainz Biomed NV's EPS (Diluted) for the three months ended in Dec. 2024 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $-25.16.

Mainz Biomed NV's EPS without NRI for the three months ended in Dec. 2024 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -25.16.

During the past 3 years, the average EPS without NRI Growth Rate was 25.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was -78.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Mainz Biomed NV's highest 3-Year average EPS without NRI Growth Rate was 25.60% per year. The lowest was -213.40% per year. And the median was -185.50% per year.

Mainz Biomed NV EPS (Basic) Historical Data

The historical data trend for Mainz Biomed NV's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV EPS (Basic) Chart

Mainz Biomed NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-2.01

-64.80

-74.55

-64.76

-22.36

Mainz Biomed NV Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial										-22.40	-15.60	-9.56	-	-

Mainz Biomed NV EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Mainz Biomed NV's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-21.651	-	0)	/	0.968
	=	-22.37

Mainz Biomed NV's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0	-	0)	/	0.968
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-25.16

Mainz Biomed NV (NAS:MYNZ) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Mainz Biomed NV EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129

Website

https://www.mainzbiomed.com

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.